A study on a sensitive assay of AKBR for rapid evaluation of pathophysiological state of liver

AKBR快速评价肝脏病理生理状态的灵敏检测方法研究

基本信息

  • 批准号:
    08557070
  • 负责人:
  • 金额:
    $ 4.48万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 无数据
  • 项目状态:
    已结题

项目摘要

A new rapid method for the measurement of arterial blood ketone body concentration and determination of arterial blood ratio (AKBR) was developed last year. This method involves the generation of NADH from NAD^+ in proportion to the concentration of beta-hydroxybutyrate in the presence of beta-hydroxybutyrate dehydrogenase. NADH is reached with oxygen in the presence of NADH oxidase to produce hydrogen peroxide. The oxidative coupling reaction of 3-methyl-2-benzothiazolinone-hydrazone-6-sulfate (MBTH-S) and N-ethyl-N-sulfopropyl-3,5-dimenthylaniline (MAPS) produces a red-purple product in the presence of peroxidase. The concentration of beta-hydroxybutyrate is determined by measuring the increase in intensity of the color. The acetoacetate concentration is determined by completely converting it to beta-hydroxybutyrate, in the presence of beta-hydroxybutyrate dehydrogenase, and then assaying the total beta-hydroxybutyrate concentration. The acetoacetate concentration is obtained by subtraction of beta-hydroxybutyrate concentration from the total ketone body concentration. We have been studying reaction conditions between MBTH-S (or MBTH analog) as a coupler and Trinder's reagent to get a higher sensitivity. MBTH analog ; 2- [(methylsulfonyl) hydrazono] -2,3-dihydro-3-methyl-6-benzothiazole-sulfonic acid (A) 2-hydrazone-2,3-dihydro-3-methyl-6-benzo-thiazolesulfonyl aminoacetic acid (B)Results Sensitivity using MBTH-S and MAPS in this buffer (pH 8.0) became twofold as high as the one in the current condition, though the increase of the reagent blank was larger, which had a bad influence on the reproducibility. We are studying the method to improve it. Neither A nor B brought higher sensitivity or stability than MBTH-S.
去年发展了一种新的快速测定动脉血酮体浓度和测定动脉血比率(AKBR)的方法。该方法涉及在β-羟基丁酸脱氢酶存在下,由NAD^+生成与β-羟基丁酸浓度成比例的NADH。在NADH氧化酶的存在下,NADH与氧气反应生成过氧化氢。3-甲基-2-苯并噻唑啉酮-腙-6-硫酸酯(MBTH-S)与N-乙基-N-磺丙基-3,5-二甲基苯胺(MAPS)在过氧化物酶存在下发生氧化偶联反应,生成紫红色产物。通过测量颜色强度的增加来确定β-羟基丁酸酯的浓度。通过在β-羟基丁酸脱氢酶存在下将其完全转化为β-羟基丁酸,然后测定总β-羟基丁酸浓度,测定乙酰乙酸浓度。通过从总酮体浓度中减去β-羟基丁酸酯浓度获得乙酰乙酸酯浓度。为了获得更高的灵敏度,我们研究了MBTH-S(或MBTH类似物)作为偶联剂与Trinder试剂的反应条件。MBTH类似物; 2- [(甲磺酰基)亚肼基]-2,3-二氢-3-甲基-6-苯并噻唑磺酸(A)2-腙-2,3-二氢-3-甲基-6-苯并噻唑磺酰基氨基乙酸(B)结果在该缓冲液中使用MBTH-S和MAPS的灵敏度(pH 8.0)变为当前条件下的两倍,尽管试剂空白的增加更大,这对再现性有不良影响。A和B的灵敏度和稳定性都没有MBTH-S高。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H. Sakumoto: "Ketone body ratios of capillary blood compared with that of arterial blood" Clin. Chim. Acta. 248. 205-207 (1996)
H. Sakumoto:“毛细血管血与动脉血的酮体比率”Clin。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y. Terada: "Ketone body ratios of the superior and inferior vena cava and of pulmonary arterial blood compared to that of arterial blood : central venous ketone body ratio as a substitute for the arterial ketone body ratio" Clin. Chim. Acta. 247. 81-88 (1
Y. Terada:“上腔静脉和下腔静脉以及肺动脉血的酮体比率与动脉血相比:中心静脉酮体比率替代动脉酮体比率”Clin。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S. Morikawa: "Glucose and energy metabolism in rat liver after ischemic damage assessed by ^<13>C and ^<31>P NMR spectroscopy" J. Surg. Res.63. 393-399 (1996)
S. Morikawa:“通过 13 C 和 31 P NMR 波谱评估缺血性损伤后大鼠肝脏中的葡萄糖和能量代谢”J.Surg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Terada: "Ketone body ratios of the superior and inferior vena cava and of pulmonary arterial blood compared to that of arterial blood : central venous ketone body ratio as a substitute for the arterial ketone body ratio." Clin.Chim.Acta. 247. 81-88 (199
Y.Terada:“上腔静脉和下腔静脉以及肺动脉血与动脉血的酮体比率相比:中心静脉酮体比率替代动脉酮体比率。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y. Terada: "Ketone body ratios of the superior and inferior vena cava, pulmonary arterial and capillary blood in comparison with arterial blood" 9th European Congress on Intensive Care Medicine. 555-559 (1996)
Y. Terada:“上、下腔静脉、肺动脉和毛细血管血与动脉血的酮体比率”,第九届欧洲重症监护医学大会。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OZAWA Kazue其他文献

OZAWA Kazue的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OZAWA Kazue', 18)}}的其他基金

Metabolic evaluation using in vivo NMR spectroscopy for individual organs under serious conditions associated with reductive liver mitochondrial state
在与还原肝线粒体状态相关的严重条件下使用体内核磁共振波谱对各个器官进行代谢评估
  • 批准号:
    09307024
  • 财政年份:
    1997
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Noninvasive evaluation of the liver in brain dead donors to prevent primary non-functioning liver in transplantation : an application of ^<13>C in vivo NMR spectroscopy.
对脑死亡供体的肝脏进行无创评估以预防移植中的原发性无功能肝脏:13 C体内NMR波谱的应用。
  • 批准号:
    06404045
  • 财政年份:
    1994
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Use of Redox theory in the perioperative metabolic support and the treatment in liver surgery and transplant.
氧化还原理论在肝脏手术和移植围手术期代谢支持和治疗中的应用。
  • 批准号:
    02404053
  • 财政年份:
    1990
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Evaluation of liver graft viability in human liver transplantation.
人肝移植中肝移植物活力的评估。
  • 批准号:
    02044086
  • 财政年份:
    1990
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Quantification of operative stress for radical extended hepatectomy
根治性扩大肝切除术手术应激的量化
  • 批准号:
    63440047
  • 财政年份:
    1988
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Retional management of patients with hepatic malignancies for redical massive hepatectomy - with special reference to metabolic internsive care besed on "Redox theory".
肝脏恶性肿瘤患者红色大面积肝切除术的区域管理——特别是基于“氧化还原理论”的代谢重症监护。
  • 批准号:
    61480282
  • 财政年份:
    1986
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
老年科学代谢物β-羟基丁酸和NAD与谵妄中的炎症和神经能量衰竭有关
  • 批准号:
    10632035
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
老年科学代谢物β-羟基丁酸和NAD与谵妄中的炎症和神经能量衰竭有关
  • 批准号:
    10626524
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
老年科学代谢物β-羟基丁酸和NAD与谵妄中的炎症和神经能量衰竭有关
  • 批准号:
    10256620
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
老年科学代谢物β-羟基丁酸和NAD与谵妄中的炎症和神经能量衰竭有关
  • 批准号:
    10408167
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
老年科学代谢物β-羟基丁酸和NAD与谵妄中的炎症和神经能量衰竭有关
  • 批准号:
    10511087
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
老年科学代谢物β-羟基丁酸和NAD与谵妄中的炎症和神经能量衰竭有关
  • 批准号:
    10037630
  • 财政年份:
    2020
  • 资助金额:
    $ 4.48万
  • 项目类别:
The effect of exogenous beta-hydroxybutyrate supplementation on glucose control in type 2 diabetes
补充外源性β-羟基丁酸对2型糖尿病血糖控制的影响
  • 批准号:
    408895
  • 财政年份:
    2019
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Operating Grants
Development of a new treatment for chronic kidney disease with beta-hydroxybutyrate, a ketone body
开发一种使用酮体β-羟基丁酸治疗慢性肾病的新疗法
  • 批准号:
    19K17735
  • 财政年份:
    2019
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of exogenous beta-hydroxybutyrate supplementation on glucose control in type 2 diabetes
补充外源性β-羟基丁酸对2型糖尿病血糖控制的影响
  • 批准号:
    405535
  • 财政年份:
    2019
  • 资助金额:
    $ 4.48万
  • 项目类别:
    Operating Grants
Beta-Hydroxybutyrate: a novel metabolite regulating mitochondrial fusion
β-羟基丁酸:一种调节线粒体融合的新型代谢物
  • 批准号:
    540645-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 4.48万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了